Herpes simplex virus type 2 inhibition of Fas ligand expression

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8747-8751

  Sieg, Scott ^a   Yildirim, Zafer ^a   Smith, Dawn ^a   Kayagaki, Nobuhiko ^b   Yagita, Hideo ^b   Huang, Yung ^a   Kaplan, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CELL STRAIN K 562; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0030002766     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8747-8751.1996     Document Type: Article

References (44)

1. Andersson, M., S. Paabo, T. Nilsson, and P. Peterson. 1985. Impaired transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215-222.
2. Beier, D., J. Cox, D. Vining, P. Cresswell, and V. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152:3862-3872.
3. Bertoletti, A., A. Sette, F. Chisari, A. Penna, M. Levrero, M. Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (London) 369:407-410.
4. Braun, R., H. Teule, H. Kirchner, and K. Munk. 1984. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. J. Immunol. 132:914-919.
5. Burgert, H., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987-997.
6. Casali, P., G. Rice, and M. Oldstone. 1984. Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J. Exp. Med. 159:1322-1337.
7. Corey, L., H. Adams, Z. Brown, and K. Holmes. 1983. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 98:958-972.
8. Duerksen-Hughes, P., W. Wold, and L. Grading. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193-42110.
9. Engers, H., J. Louis, R. Zubler. and B. Hirt. 1981. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. J. Immunol. 127:2280-2285.
10. Ettinger, R., D. Panka, J. Wang, B. Slanger, S.-T. Ju, and A. Marshak-Rothstein. 1995. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J. Immunol. 154:4302-4308.
11. Frankel, N., E. Schirmer, L. Wyatt, G. Katsafanas, E. Roffman, R. Danovich, and C. June. 1990. Isolation of a new herpes virus from CD4+ T cells. Proc. Natl. Acad. Sci. USA 87:748-752.
12. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. van Endert, R. Tampe, P. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature (London) 375:415-418.
13. Gooding, L., L. Elmore, A. Tollefson, H. Brady, and W. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-346.
14. Henkart, P. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343-346.
15. Hill, A., B. Barnett, A. McMichael, and D. McGeoch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 152:2736-2741.
16. Hill, A., P. Jugovic. I. York, G. Russ, J. Bennick, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (London) 375:411-415.
17. Jefferies, W., and H. Burgert. 1990. E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins. J. Exp. Med. 172:1653-1664.
18. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
19. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777-1783.
20. Kirchner, H., C. Kleinicke, and H. Northoff. 1977. Replication of herpes simplex virus in human peripheral T lymphocytes. J. Gen. Virol. 37:547-649.
21. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. Phillips, and A. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature (London) 369:403-407.
22. Lafferty, W., R. Coombs, J. Benedetti, C. Critchlow, and L. Corey. 1987. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N. Engl. J. Med. 316:1444-1449.
23. Lowin, L., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (London) 370:650-653.
24. Matzinger, P. 1991. The JAM assay. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185-192.
25. McChesney, M., and M. Oldstone. 1987. Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu. Rev. Immunol. 5:279-304.
26. McKisic, M., F. Paturzo, D. Gaertner, R. Jacoby, and A. Smith. 1995. A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. J. Immunol. 155:3979-3986.
27. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kerchner. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (London) 323:816-819.
28. Oishi, M., K. Maeda, and S. Sugiyama. 1994. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch. Dermatol. Res. 286:396-407.
29. Posavad, C., J. Newton, and K. Rosenthal. 1994. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J. Virol, 68:4072-4074.
30. Razvi, E., and R. Welsh. 1995. Apoptosis in viral infections. Adv. Virus Res. 45:1-60.
31. Reeves, W., L. Corey, H. Adams, L. Vontver, and K. Holmes. 1981. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N. Engl. J. Med. 305:315-319.
32. Rinaldo, C., B. Richter, P. Black, R. Callery, L. Chess, and M. Hirsch. 1979. Replication of herpes simplex virus and cytomegalovirus in human leukocytes. J. Immunol. 120:130-135.
33. Sayama, K., S. Yonehara, Y. Watanabe, and Y. Miki. 1994. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330-334.
34. Schirmer, E., L. Wyatt, K. Yamanishi, W. Rodriguez, and N. Frankel. 1991. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc. Natl. Acad. Sci. USA 88:5922-5926.
35. Sieg, S., L. Xia, Y. Huang, and D. Kaplan. 1995. Specific inhibition of granzyme B by parainfluenza virus type 3. J. Virol. 69:3538-3541.
36. Sieg, S., Y. Huang, and D. Kaplan. Submitted for publication.
37. Sieg, S., Z. Yildirim, D. Smith, and D. Kaplan. Submitted for publication.
38. Signas, C., M. Katze, H. Persson, and L. Philipson. 1982. An adenovirus glycoprotein hinds heavy chains of class I transplantation antigens from man and mouse. Nature (London) 299:175-178.
39. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567-1574.
40. Vaux, D., G. Haecker, and A. Strasser. 1994. An evolutionary perspective on apoptosis. Cell 76:777-779.
41. Whitley, R. 1990. Herpes simplex viruses, p. 1843-1887. In B. Fields and D. Knipe (ed.). Fields virology. Raven Press, New York.
42. Wong, G., and D. Goeddel. 1986. Tumour necrosis factor α and β inhibit virus replication and synergize with interferons. Nature (London) 323:819-822.
43. Wrone-Smith, T., T. Johnson, B. Nelson, L. Boise, C. Thomspon, G. Nunez, and B. Nickoloff. 1995. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am. J. Pathol. 146:1079-1088.
44. York, I., C. Roop, D. Andrews, S. Riddell, F. Graham, and D. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535.